BCPC News & Events

Reports Q1 revenue $270.71M, consensus $266.5M. Ted Harris, Chairman, President and CEO of Balchem said, "The first quarter was an excellent start to the year for Balchem, with sales and earnings growth in all three segments. We delivered record first quarter net sales, adjusted EBITDA, and net earnings, as well as strong cash flows."

Balchem Plant Nutrition announced the launch of its Metalosate T.E.A.M. plant tissue analysis digital platform. "The platform helps advisors optimize nutrient balance to enhance yield potential and crop quality, while reducing unnecessary input cost in specialty crops. Built as a free service for pest control advisors and agronomists, T.E.A.M. translates plant tissue analysis results into targeted nutrition recommendations that growers can act on with confidence," the company said.

Reports Q4 revenue $263.6M, consensus $259.59M. Ted Harris, Chairman, President, and CEO of Balchem said, "In the fourth quarter, Balchem's strong growth trajectory continued. We delivered record fourth quarter net sales and adjusted EBITDA, with top and bottom line growth year over year in each of our three segments, driven by ongoing progress on our focused growth platforms and our company's alignment with the favorable 'better for you' trends."

As producers of choline chloride in the EU, Eastman and Balchem welcome the European Union's decision published on December 19, 2025 to adopt anti-dumping duties between 90.0 and 115.9% on choline chloride imports from the People's Republic of China. This decision, which will be effective for five years with the possibility of renewal, confirms Europe's determination to ensure the continuation of an important part of the EU food and feed supply chain in the face of unfair trade practices from producers in China. Defending fair trade in choline chloride is essential to preserving European jobs, encouraging industrial innovation, and supporting a strong and sustainable supply chain for EU food and feed.